Antibiotics Active Pharmaceutical Ingredients (APIs) Market 2031: China sales will account for around 22% of total global demand throughout the forecast period


The demand for API antibiotics will continue to increase at a sustained rate between 2021 and 2031. It is often the first choice for treating infections. According to a new study from Future Market Insights (IMF), the antibiotic API market is expected to exceed US $ 8.1 billion in 2021. Antibiotics are intended to make medical procedures much safer.

Any surgery or chronic disease is susceptible to bacterial infection, which puts the patient at greater risk. Rising incidence of infections such as tuberculosis, pneumonia, blood poisoning, gonorrhea, and foodborne illness is reportedly leading to increased demand for antibiotics which is expected to drive the API antibiotics market.

According to the World Health Organization (WHO), pneumonia caused by bacteria can be treated with antibiotics. About 15% of child deaths were due to pneumonia in 2017. According to UNICEF 2018 data, globally there are about 1,400 cases of pneumonia per 100,000 children, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children)

The COVID-19 pandemic is believed to be negatively impacting the antibiotic API market. Some of the major biotech companies, research institutes and pharmaceutical companies are nominated in collaboration to deal with the situation. This has shifted their focus and resources from manufacturing other drugs to coronavirus vaccines. The shortage of various APIs and restricted hospital visits due to the growing number of COVID-19 patients has rocked the global antibiotic API market.

In terms of API, Penicillin Antibiotics segment dominated the API Antibiotics market with 51.1% market share in 2021 due to increasing demand and adoption of penicillin as premier antibiotic therapy. intention to treat several bacterial infections. Pharmaceutical companies are expected to dominate the end user segment. They are expected to hold over 77% of the market and remain dominant throughout the forecast period.

Get a sample report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13025

Key Points From Antibiotics API Market Research

  • Global Antibiotics API Market is estimated to be worth US $ 8.01 billion in 2020, the market is expected to grow at a CAGR of 3.1% during the forecast period (2020-2030)
  • The United States holds over 92.1% of the North American market share, but Canada is expected to increase CAGR faster
  • UK market to show steady annual growth of 2.1% in 2021
  • Demand from Germany and France will grow at a positive pace throughout the forecast period
  • In East Asia, China will become a key market, while Japan and South Korea will continue to show steady demand

“The increasing prevalence of bacterial diseases, the extreme use of antibiotics, and increasing investment in R&D are expected to drive the growth of the antibiotic API market. »Says IMF analyst

The increasing investments in the R&D sector to develop advanced molecules is the main factor that is expected to drive the growth of the Antibiotic API market.

For example, Sandoz, the biosimilars and generics division of Novartis, is making a joint investment, with the Austrian Federal Government, to improve the long-term future of integrated antibiotics manufacturing in Europe.

The main players in the Antibiotics API enter into a strategic alliance

The main players are focused on increasing acquisitions at the regional level. Acquisitions strengthen the company’s capacity with products and increase the company’s portfolio. The company acquires to own well established products and solutions which expects to represent a good source of income for the acquirer. It also allows the company to enter new emerging markets as well as improve existing markets.

For example, in August 2019, Nanjing Dorra Pharmaceutical Technology collaborated with Meitheal Pharmaceuticals, the fully integrated generic injectable company, to increase the manufacturing capacity of active pharmaceutical ingredients in the US region. The collaboration has enabled Meitheal Pharmaceuticals to invest in Nanjing Dorra Pharmaceutical technology.

For any questions, contact us @ https://www.futuremarketinsights.com/ask-question/rep-gb-13025

Who wins?

The global Antibiotics API market is expected to expand its scope during the forecast period, owing to the increasing prevalence of various bacterial diseases and increasing investments in R&D. The antibiotics market is very competitive and consists of several major players. Pharmaceutical companies are focusing more on outsourcing antibiotic API manufacturing due to the high capital investment involved in establishing antibiotic API manufacturing units.

The main players in the market covered by FMI are Sandoz International GmbH, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR SPA, Nanjing Dorra Pharmaceutical Technology Co. Ltd., DAEWOONG PHARMACEUTICAL CO. LTD., Parabolic Drugs Ltd., Penam Laboratories Ltd., ASIATIC DRUGS & PHARMACEUTICAL PVT. LTD., Fresenius Kabi, The United Laboratories International Holdings Limited, Aurobindo Pharma Limited, Unimark Remedies Ltd., Savior Lifetec, Shenzhen Haibin Pharmaceutical Co., Ltd., Sterile India Pvt. Ltd., Zhejiang Jiuzhou Pharmaceutical Co. Ltd. and Kyongbo Pharm, consolidating their positions through mergers, acquisitions and new product launches.

Buy Industry Research Report: https://www.futuremarketinsights.com/checkout/13025

Why the future market outlook?

  • Complete analysis of the evolution of purchasing habits in different geographical areas
  • Detailed information on market segments and sub-segments for historical and forecast period
  • A competitive analysis of prominent and emerging players in the Antibiotics Active Pharmaceutical Ingredients (APIs) Market
  • Detailed information on product innovation, mergers and acquisitions planned for the coming years
  • Groundbreaking research and market player centric solutions for the next decade under the current market scenario

More related reports:

Teledentistry Market: Teledentistry Market: Global Industry Analysis 2015-2019 and Opportunity Assessment; 2020 – 2030

Rebreathless Oxygen Mask Market: Rebreathless Oxygen Mask Market: 2015-2019 Global Industry Analysis and 2020-2030 Opportunity Assessment

Intravenous Pegloticase Market: Intravenous Pegloticase Market: Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

About the IMF

Future Market Insights (FMI) is a leading provider of business information and advisory services, serving clients in more than 150 countries. IMF is headquartered in Dubai, the world’s financial capital, and has delivery centers in the United States and India. IMF’s latest market research and sector analysis reports help companies meet challenges and make critical decisions with confidence and clarity amid fierce competition. Our personalized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of analysts led by FMI experts continually monitors emerging trends and events across a wide range of industries to ensure that our clients are preparing for the changing needs of their consumers.

Contact

Unit No .: AU-01-H Gold Tower (AU), Plot No .: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For sales inquiries: [email protected]

For media inquiries: [email protected]


Comments are closed.